

BRAIN Biotech is a key player in the bio-based economy
BRAIN Biotech AG ranks among the technologically leading companies in Europe in the bioeconomy area, and operates in industrial biotechnology with its key technologies.
BRAIN Biotech identifies previously untapped high-performing enzymes, microbial producer organisms and natural compounds derived from complex biological systems to transform them into industrially usable applications.
Innovative solutions and products developed from this Toolbox of Nature are successfully deployed in the chemicals sector, as well as in the cosmetics and food manufacturing industries.
As part of its growth-oriented industrialization strategy, BRAIN Biotech AG (ISIN DE0005203947 / WKN 520394) has been the first bioeconomy company to be listed in the Prime Standard of the Frankfurt Stock Exchange since February 2016.
3M-Update – FY 2022/23
BRAIN-engineered-Cas – Elevator pitch
Speaker: Lukas Linnig, Chief Financial Officer at BRAIN Biotech until September 30, 2022.
(Video recorded in 2021)

Investor Relations
Selected publications and financial events

Investor Relations service
You want to invest in BRAIN Biotech AG or have questions? We are here for you. Please get in touch with us.